With powerful backers, iCarbonX is the most emblematic start-up, but not only one at the convergence of AI and genomics: an ever expanding network of IT and bio-computing companies is rapidly conquering the Chinese and U.S. health markets. The Consultant firm Frost & Sullivan predicts AI system will generate 6.7 billion in global revenue from health care by 2021, compared with $633.8 million in 2014. AI systems are quickly invading the lab and the clinic to make sense of the increasing trove of genomic data - by 2025, between 100 million and 2 billion human genomes could be sequenced - an effort that will exceed the computing challenges of running YouTube and Twitter.

This below map shows respective - US and China - capacities in genomics and AI and their related investments and partnerships.